Nucleic acid compounds that bind to retinoic acid-inducible gene i protein
WO2021046074A1
Cardiovascular risk event prediction and uses thereof
WO2021021678A1
Method, apparatus, and computer-readable medium for adaptive normalization of analyte levels
WO2020236544A1
Controlling intersample analyte variability in complex biological matrices
WO2020198011A1
Reducing intersample analyte variability in complex biological matrices
WO2020112478A1
Methods for determining disease risk combining downsampling of class-imbalanced sets with survival analysis
WO2020092211A1
Methods for sample quality assessment
WO2020081510A1
Nucleic acid compounds for binding immunoglobulin g
SG11202012472TA
Improved proteomic multiplex assays
US2019277842A1
Proteomic assay using quantum sensors
GB201710524D0
Controlling intersample analyte variability in complex biological matrices
WO2018005974A1
Oligonucleotides comprising modified nucleosides
CA3017853A1
Compounds and methods for the synthesis of 5-(n-protected-tryptaminocarboxyamide)-2'-deoxyuridine phosphoramidate for incorporation into a nucleic sequence
CN108603887A
Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic fatty liver disease (NASH) biomarker and application thereof
KR20180050303A
Method of developing individual drug treatment plan and target drug development method based on protein body profile
WO2016182967A1
Biomarkers for detection of tuberculosis risk
US2016324927A1
Compositions and methods for identifying, modulating and monitoring drug targets in muscular disease
US2018016581A1
Nucleic acid compounds for binding growth differentiation factor 8
